A Study to Evaluate MWN109 Injection in Healthy Subjects
Status:
RECRUITING
Trial end date:
2025-11-25
Target enrollment:
Participant gender:
Summary
This study is a Phase1, randomized, double-blinded, and placebo-controlled study. In each cohort, enrolled participants will be randomized to receive either placebo or MWN109.